Challenge Facility 2020.jpg

TBpeople global and TBpeopleUkraine are both to receive a grant for this year's CFCS.

TBpeople Global is among 31 organizations worldwide to receive a Challenge Facility (CFCS) for 2020.

Fantastic news! The Stop TB Partnership has announced the successful grantees for the Challenge Facility for Civil Society (CFCS) 2020! TBpeople Global, as well as our country chapter in Ukraine, TBpeopleUkraine, are among the 31 organizations from 13 countries and six regions who will receive grants ranging from USD 20,000 to USD 100,000.


CFCS grants will support community and civil society actors at national, regional and global levels to implement key actions to achieve the targets and commitments made in the UN High-Level Meeting Declaration on TB. In recent years many countries identified community, rights, and gender (CRG) barriers faced by TB affected communities. CFCS grants will cover a range of activities to address these barriers.

Congratulations to all grantees!


Crowd 1 Award.jpg

TBpeople are very happy to be given the Stop TB Partnership's Empowering Community Voices Award for 2019 in Hyderabad, India. 

TBpeople are the proud recipient of the Stop TB Partnership's Empowering Community Voices 2019 Award.

The 50th World Conference on Lung Health was full of events and highlights, but one thing stands out for TBpeople: our very first award!


At the Human Rights Awards Dinner, TBpeople received the Stop TB Partnership's Empowering Community Voices 2019 Award for "dedication to TB survivors and people affected by TB through community mobilization and human rights activism".


It was so exciting to see how many of our members and friends rushed to the stage when the award was announced! But no matter how much we appreciate that our efforts were recognized, we are aware of the tremendous amount of work that needs to be done to strengthen the community of people affected by TB and turn it into a truly global movement, and to make sure that rights of people affected by TB become a reality.